Clinical trial
The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or…
NCT00002331 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00002331 |
|---|---|
| Title | The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS |
| Official title | A Randomized Open-Label Study of the Tolerability and Efficacy of Clarithromycin and Ethambutol in Combination With or Without Clofazimine for the Treatment of Disseminated MAC (dMAC) in Patients With AIDS |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Mycobacterium Avium-intracellular Infection, HIV Infections |
| Intervention type | Drug |
| Interventions | Ethambutol hydrochloride, Clarithromycin, Clofazimine |
| Start date | Jan 1, 1994 |
| Primary completion | Mar 1, 1995 |
| Completion | Mar 1, 1995 |
| First posted | Aug 31, 2001 |
| Last update posted | Jan 16, 2015 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: